Association of METTL14 expression with prognosis and immunotherapy in breast cancer | Synapse
March 3, 2026Open Access
Association of METTL14 expression with prognosis and immunotherapy in breast cancer
Puntos clave
METTL14 expression is linked to breast cancer prognosis, indicating its clinical relevance.
A predictive value associated with METTL14 suggests that it could serve as a biomarker for treatment outcomes.
Observational analysis indicates that METTL14 may be a promising target in immunotherapy strategies for breast cancer.
Further investigation is necessary to validate METTL14's role as a therapeutic target due to its potential implications in treatment.
Resumen
METTL14 demonstrates significant predictive value regarding prognosis in BC. The METTL14 has the potential to serve as a predictive biomarker and a promising target for immunotherapy.